Weight loss injections in Portugal such as Wegovy and Mounjaro require a prescription and medical supervision
What the science says Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Subscribe to this journal Receive 52 print issues and online access $199.00 per year only $3.83 per issue Rent or buy this article Prices vary by article type from$1.95 to$39.95 Prices may be subject to local taxes which are calculated during checkout doi: References Wharton, S
Bartsch G, Rittmaster RS, Klocker H
There have been other failed trials with LAG-3 contenders from other companies as well, such as Immutep's eftilagimod alfa, dropped for first-line NSCLC in combination with Keytruda and chemo after a phase 3 readout earlier this year, as well as MSD's candidate favezelimab, which was abandoned in 2024 after failed trials in lung and colorectal cancers
Our cutting-edge therapies, including peptide therapy, stem cell therapy, and PRP (Platelet-Rich Plasma) therapy, are designed to treat musculoskeletal injuries, arthritis, and enhance athletic performance and recovery